Viewing Study NCT00125827


Ignite Creation Date: 2025-12-25 @ 5:11 AM
Ignite Modification Date: 2025-12-26 @ 4:16 AM
Study NCT ID: NCT00125827
Status: COMPLETED
Last Update Posted: 2014-03-19
First Post: 2005-07-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study of Oral Clofarabine Administered Daily for 5 Days in Adult Patients With Refractory Solid Tumors
Sponsor: Genzyme, a Sanofi Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module